A US jury finds that the controversial drug glyphosate was a major factor in a plaintiff's cancer. For Bayer this is highly explosive.
The agrochemical and pharmaceutical group Bayer has lost an important sub-process in the USA regarding alleged cancer risks of products of its subsidiary Monsanto. A panel of judges from the San Francisco district federal district court ruled unanimously on Tuesday that the herbicide Roundup, containing the controversial drug glyphosate, was a major contributor to plaintiff Edwin Hardeman's lymph node cancer. The process is now entering a second phase to clarify whether Monsanto fooled about risks and what the potential damages could be.
For Bayer, this case is highly explosive, as it is a trend-setting "Bellwether Case". This means in US law a kind of case in a mass case. Several of these representative cases are scheduled. They should help the parties to the dispute to be able to better estimate the extent of damage and the amount of possible settlement payments. In total, hundreds of lawsuits by farmers, gardeners and consumers have been brought together by the competent US judge Vince Chhabria.